¡¾²Î¿¼ÎÄÏס¿

  ¡¡1 Brancato R, Tavola A, Carones F. Excimer laser photorefractive keratectomy for myopia: results in 1165 eyes. Refract Corneal Surg1993;9:95ª²104

¡¡¡¡2 Tengroth B, Epstein D, Fagerholm P. Excimer laser photorefractive keratectomy for myopia. Ophthalmology 1993;100:739ª²745

¡¡¡¡3 Maguen E, Salz JJ, Nesburn AB. Results of excimer laser photorefractive keratectomy for the correction of myopia. Ophthalmology 1994;101:1548ª²1556

¡¡¡¡4 Carones F, Brancato R, Morico A. Evaluation of three different approaches to perform excimer laser photorefractive keratectomy for myopia. Ophthalmic Surg Lasers1996;27(Suppl):S458

¡¡¡¡5 Yuan MH, Deng Z, Li WL, et al. Analysis of corneal Haze and regression of bothª²sided laser in situ keratomileusis. Int J Ophthalmol(Guoji Yanke Zazhi) 2007;7(1):130ª²132

¡¡¡¡6 Chen LH, Jiang P. Progress in prevention and treatment of haze after Laser epithelial keratomileusis. Int J Ophthalmol(Guoji Yanke Zazhi) 2006;6(5):1133ª²1135

¡¡¡¡7 Gartry DS, Kerr Muir MG, Lohmann CP, et al. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. Arch Ophthalmol1992;110:944ª²952

¡¡¡¡8 Carones F,Brancato R,Venturi E.Efficacy of corticosteroids in reversing regression after myopic photorefractive keratectomy. Refract Corneal Surg 1993;9(Suppl):S52ª²S56

¡¡¡¡9 Talamo JH, Gollamudi S, Green WR. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 1991;109:1141ª²1146

¡¡¡¡10 Xu H, Liu S, Xia X. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg2001;17:342ª²349

¡¡¡¡11 Fantes FE,Hanna KD,Waring GO.Wound healing after exicmer laser keratiomileusis(photorefractive Keratectomy)in monkeys. Arch Ophthalmol 1990;108:655

¡¡¡¡12 Ambrosio R Jr, Wilson SE. Complications of laser in situ keratomileusis: etiology, prevention, and treatment. J Refract Surg2001;17:350ª²379

¡¡¡¡13 Ali¨® JL,Muftuoglu O.Tenª²year followª²up of photorefractive keratectomy for myopia of more than ª²6 diopters. Am J Ophthalmol 2008;145(1):1ª²2

¡¡¡¡14 Chabner BA, Ryan DP, Pazª²Ares L. Antineoplasic agents. The Pharmacological Basis of Therapeutics, 10th ed. New York, NY McGraw Hill 2001;1389ª²1459

¡¡¡¡15 Sacu S, Rainer G, Findl O. Correlation between the early morphological appearance of filtering blebs and outcome of trabeculectomy with mitomycin C. J Glaucoma 2003;12:430ª²435

¡¡¡¡16 Lam DSC, Wong AKK, Fan DSP. Intraoperative mitomycin C to prevent recurrence of pterygium after excision. Ophthalmology 1998;105:901ª²904

¡¡¡¡17Âí½¨»Ô,ËÎÍòÁá,ÕÔ´äÓ¢.СÁºÇгýÊõÖÐË¿ÁÑùËØCºÍ͸Ã÷ÖÊËáÄƵÄÓ¦ÓÃ.¹ú¼ÊÑÛ¿ÆÔÓÖ¾2005;5(4):782ª²784

¡¡¡¡18ÕÅÐÀ,Áº´ºÁá,ÐìÑå.·Ç´©Í¸ÐÔСÁºÊÖÊõÖÐÓ¦ÓÃË¿ÁÑùËØC 32Àý.¹ú¼ÊÑÛ¿ÆÔÓÖ¾2005;5(1):107ª²111

¡¡¡¡19 Majmudar PA, Forstot SL, Dennis RF. Topical mitomycinª²C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology2000;107:89ª²94

¡¡¡¡20 Gambato C, Ghirlando A, Moretto E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 2005;112:208ª²218

¡¡¡¡21 Chang SW. Early corneal edema following topical application of mitomycinª²C. J Cataract Refract Surg 2004;30:1742ª²1750

¡¡¡¡22 McDermott ML, Wang J, Shin DH. Mitomycin and the human corneal endothelium. Arch Ophthalmol 1994;112:533ª²537

¡¡¡¡23 Sadeghi HM, Seitz B, Hayashi S. In vitro effects of mitomycinª²C on human keratocytes. J Refract Surg1998;14:534ª²540

¡¡¡¡24 Lee DH, Chung HS, Jeon YC. Photorefractive keratectomy with intraoperative mitomycinª²C application. J Cataract Refract Surg2005;31:2293ª²2298

¡¡¡¡25 McCarty CA, Aldred GF, Taylor HR. Comparison of results of excimer laser correction of all degrees of myopia at 12 months postoperatively. Am J Ophthalmol 1996;121:372ª²383

ÉÏÒ»Ò³  [1] [2] [3]